$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Systolic Heart Failure Global Clinical Trials Review, H2, 2015
[Published by Global Data]

Published by Global Data: 23 Dec 2015 | 17888 | In Stock
Related Topics: Clinical Trials , Heart Failure

Introduction

Systolic Heart Failure Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Systolic Heart Failure Global Clinical Trials Review, H2, 2015" provides an overview of Systolic Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Systolic Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Systolic Heart Failure Global Clinical Trials Review, H2, 2015 [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

    Top Five Countries Contributing to Clinical Trials in Central and South America 14

    Clinical Trials by G7 Countries: Proportion of Systolic Heart Failure to Cardiovascular Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 16

    Clinical Trials in G7 Countries by Trial Status 17

    Clinical Trials by E7 Countries: Proportion of Systolic Heart Failure to Cardiovascular Clinical Trials 18

    Clinical Trials by Phase in E7 Countries 19

    Clinical Trials in E7 Countries by Trial Status 20

    Clinical Trials by Phase 21

    In Progress Trials by Phase 22

    Clinical Trials by Trial Status 23

    Clinical Trials by End Point Status 24

    Subjects Recruited Over a Period of Time 25

    Clinical Trials by Sponsor Type 26

    Prominent Sponsors 27

    Top Companies Participating in Systolic Heart Failure Therapeutics Clinical Trials 28

    Prominent Drugs 30

    Clinical Trial Profile Snapshots 31

    Appendix 70

    Abbreviations 70

    Definitions 70

    Research Methodology 71

    Secondary Research 71

    About GlobalData 72

    Contact Us 72

    Disclaimer 72

    Source 73

List Of Tables
in Systolic Heart Failure Global Clinical Trials Review, H2, 2015 [Published by Global Data]

List of Tables

Systolic Heart Failure Therapeutics, Global, Clinical Trials by Region, 2015* 6

Systolic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Systolic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Systolic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Systolic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Systolic Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Systolic Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Systolic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Systolic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Systolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Systolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Systolic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Systolic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Systolic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Systolic Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Systolic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Systolic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Systolic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Systolic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Systolic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26

Systolic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Systolic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Systolic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List Of Figures, Charts and Diagrams
in Systolic Heart Failure Global Clinical Trials Review, H2, 2015 [Published by Global Data]

List of Figures

Systolic Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Systolic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Systolic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Systolic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Systolic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Systolic Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Systolic Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Systolic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Systolic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Systolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Systolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Systolic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Systolic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Systolic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Systolic Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Systolic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Systolic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Systolic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Systolic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Systolic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26

Systolic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Systolic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Systolic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 71

Additional Details

Publisher

Global Data

Publisher Information

Reference

17888 | GDHC3131CTIDB

Number of Pages

73

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Systolic Heart Failure Global Clinical Trials Review, H2, 2018
Systolic Heart Failure Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial rep...
31 Aug 2018 by Global Data USD $2,500 More Info
Systolic Hypertension Global Clinical Trials Review, H2, 2018
Systolic Hypertension Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial repo...
31 Aug 2018 by Global Data USD $2,500 More Info
Systolic Hypertension-Pipeline Insights, 2017
DelveInsight’s, “ Systolic Hypertension-Pipeline Insights, 2017”, report provides in depth insights ...
30 May 2017 by Delve Insight USD $1,250 More Info
Systolic Hypertension Global Clinical Trials Review, H2, 2016
Systolic Hypertension Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial repo...
29 Jul 2016 by Global Data USD $2,500 More Info
Systolic Hypertension Global Clinical Trials Review, H2, 2016
Systolic Hypertension Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial repo...
29 Jul 2016 by Global Data USD $2,500 More Info

This report is published by Global Data

Download Free Report Summary PDF

Systolic Heart Failure Global Clinical Trials Review, H2, 2015 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)